http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Determining Sediment Rate Using Cesium-137 Fallout at the Larto Lake
고문환,Koh, Mun-Hwan,McHenry, J. Rogar 한국토양비료학회 1982 한국토양비료학회지 Vol.15 No.4
1950년대(年代)의 핵실험(核實驗)에 의(依)하여 생긴 방사능(放射能) 동위원소(同位元素)는 토양(土壤)이나 퇴사(堆砂)에 다양(多樣)하게 포함(包含)되었다. 이들 방사성(放射性) 동위원소(同位元素) 중(中)에서 $^{137}Cs$은 미세토양(微細土壤) 입자(粒子)에 고착(固着)하는 성질(性質)이 크고 방사능(放射能)의 발산량이 많고 균일(均一)하기 때문에 퇴사과정(堆砂過程)을 평가하는데 이용(利用)이 가능(可能)하다. 미국 Louisiana 주(州) Larto호(湖)에서, 낙진(落塵)된 $^{137}Cs$에 의(依)해 1958년(年) 이내로 퇴사속도(堆砂速度)를 측정(測定)한 바에 의(依)하면 연평균(年平均) 1.6~3.1cm로 퇴사(堆砂)되고 있으며, 가장 많이 퇴사(堆砂)된 곳은 70cm까지 퇴사(堆砂)되었음이 밝혀졌다. 또한 해를 거듭할수록 퇴사(堆砂)되는 율(率)이 적어지고 있으며, 퇴사(堆砂)의 입도분포(粒度分布)는 호수(湖水) 전체에 거의 $20{\mu}$이하(以下)의 미세입자(微細粒子)가 분포(分布)하고 있었다. Soils and sediments have been uniquely tagged by radioactive isotopes as a result of nuclear test explosions in the 1950's and 1960's. Fallout $^{137}Cs$ strongly fixed to fine soil particles, was measured in sediment profiles in Larto Lake to calculate the sedimentation rate as a time dependence. The Lake sediment profiles indicated an average rate of 1.6 to 3.1 cm/yr of sediment deposition since 1958. The rate of sediment depositions clearly decreased with time. Particle size distribution in sediment was reflected almost fine particles in lake.
( Min Cho Chang ),( Mohammad Al Haddad ),( Julia K. Leblanc ),( Stuart Sherman ),( Mchenry Lee ),( John Dewitt ) 대한간학회 2013 Gut and Liver Vol.7 No.2
Background/Aims: Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) and Trucut biopsy (TCB) are sensitive techniques for diagnosing mediastinal lesions, but it is unclear how either one or both should be used to obtain a pathologic diagnosis. The objective of our study was to evaluate whether EUS-TCB impacts the diagnosis of mediastinal lesions after the initial on-site review of EUS-FNA specimen suggests a suboptimal result. Methods: We enrolled consecutive patients with mediastinal lesions who underwent EUS-TCB during the same procedure if the initial EUS-FNA demonstrated an inadequate FNA sample or suggested that histopathology was required for diagnosis. Diagnostic accuracies between procedures were compared as the main outcome. Results: Twenty-seven patients (14 men; median age, 56 years; range, 19 to 82 years) underwent EUS-FNA and EUS-TCB to evaluate a mediastinal lymphadenopathy or mass (n=17), to determine the cancer stage (n=3) or to exclude tumor recurrence or metastasis (n=7). The overall diagnostic accuracies of EUS-FNA and EUS-TCB were 78% and 67%, respectively (p=0.375). The combined diagnostic accuracy of EUS-FNA plus EUS-TCB was 82%. In six patients with nondiagnostic EUS-FNA, EUS-TCB provided a final diagnosis in one patient (17%). Conclusions: In the current series of patients with mediastinal masses or adenopathy, the administration of EUS-TCB following suboptimal results for the on-site cytology review did not increase the diagnostic yield. (Gut Liver 2013;7:150-156)
Hyoung-Chul Oh,Jeffrey J. Easler,Ihab I. El Hajj,James Watkins,Evan L. Fogel,Lee McHenry,Stuart Sherman,Hyun Kang,Glen A. Lehman 대한내과학회 2020 The Korean Journal of Internal Medicine Vol.35 No.6
Background/Aims: A calcineurin inhibitor may alter pancreatic function and inflammatory reaction. This study aimed to determine the possible pharmacologic effect of the calcineurin inhibitor, tacrolimus, on pancreatic function, and to determine its preventive effect on post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in liver transplantation (LT) patients. Methods: The serum amylase and lipase values before and after LT were compared. The frequency of post-ERCP pancreatitis was compared between non-LT and LT patients, using propensity score matching method. Results: Median serum amylase values (normal range, 19 to 86 U/L) were 49.0 U/L (38.0 to 68.0) before LT and 27.0 U/L (19.3 to 36.8) after LT, and median serum lipase values (normal range, 7 to 59 U/L) were 40.0 U/L (26.5 to 54.0) before LT and 10.5 U/L (6.0 to 21.0) after LT. Both serum amylase and lipase values significantly decreased after LT (p < 0.001), and to a level comparable to chronic pancreatitis. There was a marginal significant difference between the non-LT and LT groups before the propensity score matching with respect to frequency of post-ERCP pancreatitis (16 [3.2%] in non-LT group vs. 2 [0.9%] in LT group, p = 0.069). After propensity score matching, a marginal significant difference still existed with respect to frequency of post-ERCP pancreatitis (7 [4.8%] in non-LT group vs. 1 [0.7%] in LT group, p = 0.067). Conclusions: The immunosuppression with calcineurin inhibitor may reduce not only the pancreatic enzyme dynamics but also inciting inflammatory event including post-ERCP pancreatitis.
Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents
Hyoung-Chul Oh,Ihab I. El Hajj,Jeffrey J. Easler,James Watkins,Evan L. Fogel,Lee McHenry,Glen A. Lehman,Jung Sik Choi,Hyun Kang,Stuart Sherman 거트앤리버 소화기연관학회협의회 2018 Gut and Liver Vol.12 No.2
Background/Aims: This study aimed to determine the risk of post-endoscopic retrograde cholangiopancreatography (post-ERCP) bleeding among patients taking antiplatelet agents (APAs), particularly in the era of multiple APAs. Methods: The primary outcomes were the frequency, type, and severity of ERCP-related bleeding according to the use of APAs. Results: The frequencies of post-ERCP bleeding among the four different groups were 16 of 2,083 (0.8%) in the no drug group, 12 of 256 (4.7%) in the aspirin group, 3 of 48 (6.3%) in the single APA group, and 4 of 48 (8.3%) in the multiple APA group (p<0.001). In the univariate analysis, post-ERCP bleeding was associated with age, pull-type sphincterotomy, and APA and was inversely associated with balloon dilation of the biliary orifice. In the multivariate analysis, pull-type sphincterotomy (odds ratio [OR], 7.829; 95% confidence interval [CI], 1.411 to 43.453; p=0.019) and country (Korea: OR, 0.124; 95% CI, 0.042 to 0.361; p<0.001) were associated with post-ERCP bleeding. Conclusions: The frequency of post-ERCP bleeding was statistically higher in patients on any APA within 6 days prior to ERCP. However, in the multivariate analysis, APA use was not associated with post-ERCP bleeding. Until a large, adequately powered study to detect differences is performed, caution is recommended when considering invasive procedures during ERCP in patients on APAs.
( Hyoung-chul Oh ),( Chang-il Kwon ),( Ihab I. El Hajj ),( Jeffrey J. Easler ),( James Watkins ),( Evan L. Fogel ),( Lee Mchenry ),( Stuart Sherman ),( Michelle K. Zimmerman ),( Glen A. Lehman ) 대한간학회 2017 Gut and Liver Vol.11 No.6
Background/Aims: This study aimed to evaluate the diagnostic role of low serum amylase and lipase values in the detection of chronic pancreatitis. Methods: Patients underwent endoscopic retrograde cholangiopancreatography and were diagnosed with non-calcific chronic pancreatitis (NCCP; n=99) and calcific chronic pancreatitis (CCP; n=112). Patient serum amylase and lipase values were compared with those of healthy controls (H; n=170). Results: The median serum amylase (normal range, 19 to 86 U/L) and lipase values (7 to 59 U/L) (P25-P75) were 47.0 (39.8 to 55.3) and 25.0 (18.0 to 35.0) for H, 34.0 (24.5 to 49.0) and 19.0 (9.0 to 30.0) for NCCP, and 30.0 (20.0 to 40.8) and 10.0 (3.0 to 19.0) for CCP, respectively. The cutoff values with the highest diagnostic accuracy for discriminating NCCP from H were 40 U/L for amylase and 20 U/L for lipase, respectively, and for CCP from H were 38 U/L for amylase and 15 U/L for lipase, respectively. For the diagnosis of NCCP with a criterion of serum amylase <40 and lipase <20 U/L, the sensitivity, specificity, positive predictive value, and negative predictive values were 37.4%, 88.8%, 66.1%, and 70.9%, respectively. Conclusions: Serum amylase and/or lipase levels below the normal serum range are highly specific for chronic pancreatitis patients. Clinicians should not ignore low serum pancreatic enzyme values. (Gut Liver 2017;11:878-883)